Cell-permeable NM23 blocks the maintenance and progression of established pulmonary metastasis

Cancer Research

Volumn 71, Issue 23, 2011, Pages 7216-7225

  Lim, Junghee ^a,c   Jang, Giyong ^a   Kang, Seeun ^a   Lee, Guewha ^a   Nga, Do Thi Thuy ^b   Phuong, Do Thi Lan ^b   Kim, Hyuncheol ^c   El Rifai, Wael ^d   Ruley, H Earl ^d   Jo, Daewoong ^a,b,d  

^a ProCell R and D Institute   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Sogang University   (South Korea)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE NM23;

ADJUVANT THERAPY; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; HYDROPHOBICITY; LUNG METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; SURVIVAL TIME;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL-PENETRATING PEPTIDES; DISEASE PROGRESSION; FEMALE; HCT116 CELLS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MOLECULAR SEQUENCE DATA; MOLECULAR TARGETED THERAPY; NEOPLASM METASTASIS; NIH 3T3 CELLS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PROTEIN SORTING SIGNALS; RECOMBINANT FUSION PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 82655189970     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-2015     Document Type: Article

References (41)

1. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009;9:274-84.
2. Riethdorf S, Wikman H, Pantel K. Review: biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 2008;123:1991-2006.
3. Smith SC, Theodorescu D. Learning therapeutic lessons from metastasis suppressor proteins. Nat Rev Cancer 2009;9:253-64.
4. Marshall JC, Collins J, Marino N, Steeg P. The Nm23-H1 metastasis suppressor as a translational target. Eur J Cancer 2010;46:1278-82.
5. Hartsough MT, Steeg PS. Nm23/nucleoside diphosphate kinase in human cancers. J Bioenerg Biomembr 2000;32:301-8.
6. Leone A, Flatow U, King CR, Sandeen MA, Margulies IM, Liotta LA, et al. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 1991;65:25-35. (Pubitemid 121001210)
7. Leone A, Flatow U, VanHoutte K, Steeg PS. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 1993;8:2325-33. (Pubitemid 23252360)
8. Parhar RS, Shi Y, Zou M, Farid NR, Ernst P, al-Sedairy ST. Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells. Int J Cancer 1995;60:204-10.
9. Baba H, Urano T, Okada K, Furukawa K, Nakayama E, Tanaka H, et al. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. Cancer Res 1995;55:1977-81.
10. Miyazaki H, Fukuda M, Ishijima Y, Takagi Y, Iimura T, Negishi A, et al. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture. Clin Cancer Res 1999;5:4301-7. (Pubitemid 30013819)
11. Hartsough MT, Morrison DK, Salerno M, Palmieri D, Ouatas T, Mair M, et al. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem 2002;277:32389-99. (Pubitemid 34969057)
12. Palmieri D, Halverson DO, Ouatas T, Horak CE, Salerno M, Johnson J, et al. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. J Natl Cancer Inst 2005;97:632-42. (Pubitemid 40812627)
13. Otsuki Y, Tanaka M, Yoshii S, Kawazoe N, Nakaya K, Sugimura H. Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc Natl Acad Sci U S A 2001;98:4385-90. (Pubitemid 32294986)
14. Palacios F, Schweitzer JK, Boshans RL, D'Souza-Schorey C. ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat Cell Biol 2002;4:929-36. (Pubitemid 35469422)
15. Murakami M, Meneses PI, Knight JS, Lan K, Kaul R, Verma SC, et al. Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1. Int J Cancer 2008;123:500-10. (Pubitemid 351898406)
16. Jung H, Seong HA, Ha H. Direct interaction between NM23-H1 and macrophage migration inhibitory factor (MIF) is critical for alleviation of MIF-mediated suppression of p53 activity. J Biol Chem 2008;283:32669-79.
17. Kaetzel DM, McCorkle JR, Novak M, Yang M, Jarrett SG. Potential contributions of antimutator activity to the metastasis suppressor function of NM23-H1. Mol Cell Biochem 2009;329:161-5.
18. Hawiger J. Noninvasive intracellular delivery of functional peptides and proteins. Curr Opin Chem Biol 1999;3:89-94. (Pubitemid 29118986)
19. Jo D, Lin Q, Nashabi A, Mays DJ, Unutmaz D, Pietenpol JA, et al. Cell cycle-dependent transduction of cell-permeant Cre recombinase proteins. J Cell Biochem 2003;89:674-87. (Pubitemid 36759129)
20. Jo D, Liu D, Yao S, Collins RD, Hawiger J. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med 2005;11:892-8. (Pubitemid 41161123)
21. Jo D, Nashabi A, Doxsee C, Lin Q, Unutmaz D, Chen J, et al. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat Biotechnol 2001;19:929-33. (Pubitemid 32947570)
22. Moore DJ, Zienkiewicz J, Kendall PL, Liu D, Liu X, Veach RA, et al. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes. PLoS One 2010;5:e13235.
23. Liu D, Liu XY, Robinson D, Burnett C, Jackson C, Seele L, et al. Suppression of staphylococcal enterotoxin B-induced toxicity by a nuclear import inhibitor. J Biol Chem 2004;279:19239-46. (Pubitemid 38623355)
24. Chow NH, Liu HS, Chan SH. The role of nm23-H1 in the progression of transitional cell bladder cancer. Clin Cancer Res 2000;6:3595-9.
25. Gump JM, Dowdy SF. TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med 2007;13:443-8. (Pubitemid 47562310)
26. Raagel H, Saalik P, Pooga M. Peptide-mediated protein delivery- Which pathways are penetrable? Biochim Biophys Acta 2010;1798:2240-8.
27. Sarko D, Beijer B, Boy RG, Nothelfer EM, Leotta K, Eisenhut M, et al. The pharmacokinetics of cell-penetrating peptides. Mol Pharm 2010;7:2224-31.
28. Murakami M, Meneses PI, Lan K, Robertson ES. The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration. Cancer Biol Ther 2008;7:677-88.
29. Damo LA, Snyder PW, Franklin DS. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways. Mol Carcinog 2005;42:109-20.
30. Bitler BG, Schroeder JA. Anti-cancer therapies that utilize cell penetrating peptides. Recent Pat Anticancer Drug Discov 2010;5:99-108.
31. Arnaud-Dabernat S, Bourbon PM, Dierich A, Le Meur M, Daniel JY. Knockout mice as model systems for studying nm23/NDP kinase gene functions. Application to the nm23-M1 gene. J Bioenerg Biomembr 2003;35:19-30. (Pubitemid 36667577)
32. Postel EH, Zou X, Notterman DA, La Perle KM. Double knockout Nme1/Nme2 mouse model suggests a critical role for NDP kinases in erythroid development. Mol Cell Biochem 2009;329:45-50.
33. Kaul R, Murakami M, Kumar P, Robertson ES. Nm23 as a metastasis inhibitor. In: Thomas-Tikhonenko A, editor. Cancer genome and tumor microenvironment. New York: Springer Science + Business Media, LLC; 2010. p. 233-71.
34. Okabe-Kado J, Kasukabe T, Hozumi M, Honma Y, Kimura N, Baba H, et al. A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require it's kinase activity. FEBS Lett 1995;363:311-5.
35. Willems R, Slegers H, Rodrigus I, Moulijn AC, Lenjou M, Nijs G, et al. Extracellular nucleoside diphosphate kinase NM23/NDPK modulates normal hematopoietic differentiation. Exp Hematol 2002;30:640-8. (Pubitemid 34831684)
36. Niitsu N, Okabe-Kado J, Nakayama M, Wakimoto N, Sakashita A, Maseki N, et al. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia. Blood 2000;96:1080-6. (Pubitemid 30616876)
37. Mahanta S, Fessler SP, Park J, Bamdad C. A minimal fragment of MUC1 mediates growth of cancer cells. PLoS One 2008;3:e2054.
38. Okabe-Kado J, Kasukabe T, Honma Y, Kobayashi H, Maseki N, Kaneko Y. Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells. Cancer Sci 2009;100:1885-94.
39. Lilly AJ, Khanim FL, Hayden RE, Luong QT, Drayson MT, Bunce CM. Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone. Cancer Res 2011;71:1177-86.
40. Heitz F, Morris MC, Divita G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol 2009;157:195-206.
41. Mack GS, Marshall A. Lost in migration. Nat Biotechnol 2010;28:214-29.